中国中药(00570.HK) 公布,经国家药监局完成技术审评、现场核查、抽样检验等一系列工作程序,同济堂制药申报的1.1类中药创新药醒脾解郁片已获得批准上市,药品上市许可持有人为同济堂制药。(ha/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-04 16:25。)AASTOCKS新闻
Source Link中国中药(00570.HK) 公布,经国家药监局完成技术审评、现场核查、抽样检验等一系列工作程序,同济堂制药申报的1.1类中药创新药醒脾解郁片已获得批准上市,药品上市许可持有人为同济堂制药。(ha/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-04 16:25。)AASTOCKS新闻
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.